Compare SVV & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVV | CERT |
|---|---|---|
| Founded | 1954 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2023 | 2020 |
| Metric | SVV | CERT |
|---|---|---|
| Price | $10.41 | $10.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $13.67 | $12.78 |
| AVG Volume (30 Days) | 765.5K | ★ 1.8M |
| Earning Date | 02-19-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $1,616,273,000.00 | $415,551,000.00 |
| Revenue This Year | $9.98 | $10.75 |
| Revenue Next Year | $6.33 | $6.32 |
| P/E Ratio | ★ N/A | $147.84 |
| Revenue Growth | 6.45 | ★ 11.47 |
| 52 Week Low | $6.48 | $8.03 |
| 52 Week High | $13.89 | $15.69 |
| Indicator | SVV | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 64.71 |
| Support Level | $10.20 | $9.20 |
| Resistance Level | $10.72 | $10.21 |
| Average True Range (ATR) | 0.45 | 0.37 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 58.04 | 92.14 |
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, merchandise, and sells these items in its stores.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.